Leo Pharma to withdraw from a quarter of its markets

Citing operating costs, Leo Pharma is dropping out of 22 of its 80 markets.

Photo: Leo Pharma / PR

Leo Pharma has decided to back out of 22 of its 80 markets, Danish financial daily Børsen reports.

The firm reports that it does not make financial sense for Leo Pharma to continue to operate in these countries, as the price the pharmaceutical company wants for its drugs is not being met.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs